Large-scale testing (Phase 3)Study completedNCT04684524What this trial is testingDupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)Who this might be right forAllergic Fungal Rhinosinusitis Sanofi 62
Large-scale testing (Phase 3)WithdrawnNCT06461949What this trial is testingStudy of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid SprayWho this might be right forAllergic Fungal Rhinosinusitis (AFRS)Chronic Rhinosinusitis (CRS)Asthma+1 more National Institute on Deafness and Other Communication Disorders (NIDCD)
Large-scale testing (Phase 3)Ended earlyNCT05545072What this trial is testingAdd-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)Who this might be right forAllergic Fungal Rhinosinusitis Emory University 5
Very early researchUnknownNCT04267042What this trial is testingComparing Budesonide Via MAD or INSI Prospective Cohort StudyWho this might be right forChronic Rhinosinusitis With Nasal PolypsAllergic Fungal Sinusitis St. Paul's Hospital, Canada 60